STOCK TITAN

Foresight Autonomous (FRSX) grants director 1,000,000 RSU-linked Ordinary Shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Raz-Avayo Vered reported acquisition or exercise transactions in this Form 4 filing.

Foresight Autonomous Holdings Ltd. director Vered Raz-Avayo reported a grant of restricted share units (RSUs) covering 1,000,000 Ordinary Shares on July 23, 2026, with vesting through January 1, 2029. After this award, the filing reports direct interest in 1,150,000 Ordinary Shares, which are listed as American Depository Shares where one ADS represents 90 Ordinary Shares.

Positive

  • None.

Negative

  • None.
Insider Raz-Avayo Vered
Role Director
Type Security Shares Price Value
Grant/Award Ordinary Shares F1, F2 1,000,000 $0.00 $0.00
Holdings After Transaction: Ordinary Shares — 1,150,000 shares (Direct)
Footnotes (2)
  1. F1. Includes 1,000,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.
  2. F2. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.
RSUs granted 1,000,000 Ordinary Shares Grant of restricted share units covering Ordinary Shares on 2026-07-23
Direct holdings after award 1,150,000 Ordinary Shares Reported direct interest following the RSU grant
ADS to Ordinary Share ratio 1 ADS = 90 Ordinary Shares Representation ratio for issuer’s listed securities
RSU vesting end date January 1, 2029 RSUs covering 1,000,000 Ordinary Shares vest through this date
restricted share units ("RSUs") financial
"Includes 1,000,000 ordinary shares... issuable upon the vesting of restricted share units ("RSUs")"
American Depository Shares ("ADS") financial
"The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares"
no par value per share financial
"Includes 1,000,000 ordinary shares, no par value per share, of the Issuer"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Foresight Autonomous (FRSX) disclose for Vered Raz-Avayo?

Foresight Autonomous disclosed that director Vered Raz-Avayo received a grant of restricted share units (RSUs) covering 1,000,000 Ordinary Shares on July 23, 2026. These RSUs vest over time through January 1, 2029, as described in the filing footnotes.

How many FRSX shares does Vered Raz-Avayo hold after the reported RSU grant?

After the RSU grant, the filing reports Vered Raz-Avayo’s direct interest as 1,150,000 Ordinary Shares. This figure includes 1,000,000 Ordinary Shares issuable upon vesting of RSUs that extend through January 1, 2029, according to the disclosure.

What are the key terms of the 1,000,000 RSUs reported for FRSX’s director?

The award consists of 1,000,000 restricted share units (RSUs), each representing the right to receive one Ordinary Share. These RSUs vest over time through January 1, 2029, meaning the underlying Ordinary Shares become issuable as vesting conditions are met.

How are Foresight Autonomous (FRSX) Ordinary Shares represented as ADSs?

Foresight Autonomous states its securities are listed as American Depository Shares (ADSs), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time at the holder’s election, and the ADSs have no expiration date under the disclosed terms.

Does the Form 4 for FRSX indicate a purchase or a grant for Vered Raz-Avayo?

The Form 4 reports an acquisition via grant or award, coded as transaction type A, rather than an open-market purchase. It reflects a compensation-related grant of RSUs covering 1,000,000 Ordinary Shares, not a purchase at a cash price per share.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Raz-Avayo Vered

(Last)(First)(Middle)
C/O FORESIGHT AUTOMOMOUS
7 GOLDA MEIR ISRAEL

(Street)
NESS ZIONA7414001

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Foresight Autonomous Holdings Ltd. [ FRSX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/23/2026A1,000,000(1)A$01,150,000(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes 1,000,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.
2. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.
/s/ Vered Raz-Avayo07/27/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)